and the action of the angiotensin II molecule, once synthesized, can be blocked at the receptor. In practice, only ACE inhibitors and ARBs have provided safe and effective management of ...

In a randomized controlled trial of people with type 2 diabetes, albuminuria, and estimated glomerular filtration rate (eGFR) between 25 and 75 mL/min/1.73 m2, subcutaneous semaglutide reduced the ...

Chika E. Okereke, MD; Franz H. Messerli, MD, Department of Internal Medicine, Section on Hypertensive Diseases, Ochsner Clinic and Alton Ochsner Medical Foundation, New Orleans, LA ...

1 is the largest systematic review of published randomized clinical trials evaluating the use of angiotensin-converting enzyme (ACE) inhibitors (ACEIs) and angiotensin-II-receptor blockers (ARBs ...

The study investigators originally planned to enroll 2,364 patients with type 2 diabetes ... 1 All patients received standard treatment for diabetic nephropathy (including angiotensin-converting ...

On November 18, at the American Heart Association (AHA) 100th Annual Meeting 2024, the safety of glucagon-like peptide-1 ...